Arizona State Retirement System grew its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 1.1% during ...

Guardant Health has an expanding pipeline that could significantly boost its future market potential. Check out my ...

Principal Financial Group Inc. trimmed its position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 8.0% in ...

The presence of primary resistance and KRAS G12C co-mutations may explain limited single-agent efficacy of marketed KRAS inhibitors, a recent study suggests.

We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going ...

We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going to take a look at where Guardant Health, Inc. (NASDAQ:GH) stands ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

The increase in precision oncology revenue was also attributable to an increase in reimbursement for tests due to an increase in Medicare reimbursement for the Guardant360 LDT test to $5,000 and ...

Key contributors included strong clinical revenue and double-digit growth in Guardant360 test volumes. Management emphasized major milestones for Guardant360, including its transition to the Smart ...

Guardant360 LDT and Guardant360 CDx are its flagship therapy selection tests, and most of the firm’s current revenue is derived from this segment. 360 LDT was launched in 2014 as a lab developed ...

Precision oncology revenue grew 30%, to $184.6 million for the fourth quarter of 2024, from $142.2 million for the corresponding prior year period, driven by an increase in the volume of clinical ...

The increase in precision oncology revenue was also attributable to an increase in reimbursement for our tests, due to an increase in Medicare reimbursement for our Guardant360 LDT test to $5,000 ...